On 30 November 2017, NHS England and the National Institute for Health Research (NIHR) published a joint statement that committed to 12 actions to support and apply research in the NHS. The first of these actions was to "manage Excess Treatment Costs better". This emphasis on simplifying and improving research arrangements is ultimately intended to improve future health and care for patients.
In connection with this, between November 2017 and February 2018, NHS England, working in partnership with the Department of Health and Social Care (DHSC), the Health Research Authority (HRA) and the NIHR, held a public consultation on proposals to:
better manage excess treatment costs (action 1)
further improve and eliminate delays in commercial contract research set-up and reporting (action 2)
Following the consultation it was decided that from 1st October 2018 the NIHR Clinical Research Network (CRN) will manage national operational oversight of the excess treatment costs (ETCs), establishing a new centralised ETC process for services commissioned by CCGs.
Our regional NIHR Yorkshire and Humber Clinical Research Network (Y&H CRN) will now manage the process across Yorkshire and Humber, meaning that any new applications for ETCs within Yorkshire and Humber should now be applied for under the new system via the Schedule of Events Cost Attribution Template (SoECAT) liaising with the local AcoRD specialists who can be contacted via the CRN’s study support services.
The following links provide access to and guidance on how to complete the SoECAT:
Any recruitment after 1st October will be managed by the new system; payments by participants recruited (per patient cost) will only be triggered once a Trust has achieved its absorption threshold. The absorption thresholds have been shared with Trusts in a letter from the NIHR CRN Coordinating Centre (CRN CC). Payments will be made quarterly in arrears based upon recruitment as recorded within the Central Portfolio Management System (CPMS).
In primary care, general practices must cover any excess treatment costs. These will then be reimbursed quarterly in arrears by the CRN once a trigger point of £100 has been reached. If none of the ETCs are higher than £100, the total will be reimbursed at the end of the financial year.